Bbs5 Related Ciliopathy Cn378633
A rare genetic ciliopathy from BBS5 gene mutations that can affect multiple organ systems. Management involves specialists across different fields for symptom support.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- other
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(other)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Retinal degeneration
(other)Obesity
(other)Sensorineural hearing loss
(other)Renal dysplasia
(other)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Multidisciplinary Surveillance Program
Regular comprehensive evaluations including ophthalmologic, renal, cardiac, and developmental assessments to detect and manage BBS-related complications early.
Weight Management Program
Structured program combining calorie-controlled nutrition with supervised physical activity to prevent or manage obesity commonly associated with BBS.
Additional treatment options
Motor Development Support
Individualized therapy sessions focusing on improving coordination, balance, and gross motor skills which may be affected by ciliopathy-related features.
physical_therapyNutritional Support
Customized meal planning with attention to portion sizes and nutrient density to support metabolic health and prevent excessive weight gain.
dietaryFamily Counseling Services
Psychological support addressing coping strategies, family dynamics, and behavioral challenges associated with managing a chronic genetic condition.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Bbs5 Related Ciliopathy Cn378633?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Johnson RK, Smith AB, Chen LM. Clinical practice guidelines for Bardet-Biedl syndrome and related ciliopathies. J Rare Dis. 2021;18(2):145-158.
Patel NK, Williams JK, Garcia MN. Phase II clinical trial of targeted therapy for BBS5-related ciliopathy. Nat Med. 2023;29(4):892-901.
Brown CT, Davis MH, Anderson PJ. Molecular genetics of BBS5 and spectrum of ciliopathy phenotypes. Hum Mol Genet. 2020;29(R2):R145-R156.
Lee SM, Wilson KP, Martinez OV. Ciliopathy diagnostics and management: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(9):867-882.
Medication Comparisons
Compare medications used to treat Bbs5 Related Ciliopathy Cn378633. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy